Physician profile
John E Murphy III
NPI 1659352920
$1,669.29
in general payments reported to CMS, 2019-2025
17 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,073 · 2020: $43.48 · 2022: $27.99 · 2023: $172 · 2024: $242 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $724.76 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $205.42 | 2019 | |
| Novo Nordisk INC | $154.39 | 2019 | |
| Janssen Pharmaceuticals, INC | $149.00 | 2019 | |
| Abbvie INC. | $114.99 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $59.97 | 2019 | |
| Lilly USA, LLC | $55.55 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.38 | 2019 | |
| Astellas Pharma US INC | $44.19 | 2019 | |
| Amgen INC. | $21.31 | 2019 | |
| Smith+Nephew, INC. | $17.81 | 2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Circassia INC. | $13.37 | 2019 | |
| Horizon Therapeutics Plc | $13.19 | 2019 | |
| Hologic Sales and Service, LLC | $13.17 | 2019 | |
| Merck Sharp & Dohme LLC | $12.92 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.58 | 2019 | |
| Shire North American Group INC | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Murphy III listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.